alcoholic fatty liver disease
alcoholic fatty liver disease
Explore linked clinical trials. Standard reference: MONDO:00211043 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD) | Chemically-Induced Disorders, Digestive System Diseases, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, fatty liver disease, liver disorder, substance-related disorder | Not yet recruiting | Phase 2 | 2026-04-29 | NCT07466485 | |
| A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis | Brain Diseases, Metabolic, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, brain disorder, central nervous system disorder, cirrhosis of liver, fatty liver disease, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nervous system disorder, substance-related disorder | Recruiting | Phase 3 | 2026-02-24 | NCT06461208 | |
| Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly | Chemically-Induced Disorders, Digestive System Diseases, Hepatomegaly, Hypertrophy, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2025-07-23 | NCT07068191 |